Profile and sites of eicosanoid release in experimental necrotizing enterocolitis.
Miller
M J
MJ
Department of Pharmacology, New York Medical College, Valhalla 10595.
Clark
D A
DA
D000818:Animals; D001681:Biological Assay; D004195:Disease Models, Animal; D004761:Enterocolitis, Pseudomembranous / Q000503:physiopathology*; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism*; D007975:Leukotriene B4 / Q000378:metabolism*; D008297:Male; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D010477:Perfusion; D011453:Prostaglandins / Q000378:metabolism*; D011817:Rabbits; D013189:SRS-A / Q000378:metabolism*; D013929:Thromboxane B2 / Q000378:metabolism; D014655:Vascular Resistance
D011453:Prostaglandins; D013189:SRS-A; D007975:Leukotriene B4; D013929:Thromboxane B2; D009240:N-Formylmethionine Leucyl-Phenylalanine; D007213:Indomethacin